Logo

Psoriasis Drugs Market Size, Share, and Growth Forecast, 2026 - 2033

Psoriasis Drugs Market by Treatment Modality (Biologic Drugs, Others), Drug Class (TNF-α Inhibitors, IL-12/23 Inhibitors, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Regional Analysis for 2026 - 2033

ID: PMRREP25102
Calendar

May 2026

195 Pages

Author : Abhijeet Surwase

Healthcare
  1. Executive Summary
    1. Global Psoriasis Drugs Market Snapshot, 2026 and 2033
    2. Market Opportunity Assessment, 2026 - 2033, US$ Bn
    3. Key Market Trends
    4. Future Market Projections
    5. Premium Market Insights
    6. Industry Developments and Key Market Events
    7. PMR Analysis and Recommendations
  2. Market Overview
    1. Market Scope and Definition
    2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
    3. COVID-19 Impact Analysis
    4. Forecast Factors - Relevance and Impact
  3. Value Added Insights
    1. Value Chain Analysis
    2. Key Market Players
    3. Regulatory Landscape
    4. PESTLE Analysis
    5. Porter’s Five Force Analysis
    6. Consumer Behavior Analysis
  4. Price Trend Analysis, 2020-2025
    1. Key Factors Impacting Product Prices
    2. Pricing Analysis, By Treatment Modality
    3. Regional Prices and Product Preferences
  5. Global Psoriasis Drugs Market Outlook
    1. Market Size (US$ Bn) Analysis and Forecast
      1. Historical Market Size (US$ Bn) Analysis, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, 2026-2033
    2. Global Psoriasis Drugs Market Outlook: Treatment Modality
      1. Historical Market Size (US$ Bn) Analysis, By Treatment Modality, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, By Treatment Modality, 2026-2033
        1. Biologic Drugs
        2. Small-molecule Systemic Drugs
        3. Topical Agents
        4. Combination Regimens
      3. Market Attractiveness Analysis: Treatment Modality
    3. Global Psoriasis Drugs Market Outlook: Drug Class
      1. Historical Market Size (US$ Bn) Analysis, By Drug Class, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026-2033
        1. TNF-α Inhibitors
        2. IL-12/23 Inhibitors
        3. IL-17 Inhibitors
        4. IL-23 Inhibitors
        5. PDE4 Inhibitors
        6. TYK2 Inhibitors
        7. Other
      3. Market Attractiveness Analysis: Drug Class
    4. Global Psoriasis Drugs Market Outlook: Distribution Channel
      1. Historical Market Size (US$ Bn) Analysis, By Distribution Channel, 2020-2025
      2. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026-2033
        1. Hospital Pharmacies
        2. Retail Pharmacies
        3. Online Pharmacies
      3. Market Attractiveness Analysis: Distribution Channel
  6. Global Psoriasis Drugs Market Outlook: Region
    1. Historical Market Size (US$ Bn) Analysis, By Region, 2020-2025
    2. Market Size (US$ Bn) Analysis and Forecast, By Region, 2026-2033
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
    3. Market Attractiveness Analysis: Region
  7. North America Psoriasis Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Treatment Modality
      3. By Drug Class
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026-2033
      1. U.S.
      2. Canada
    3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Modality, 2026-2033
      1. Biologic Drugs
      2. Small-molecule Systemic Drugs
      3. Topical Agents
      4. Combination Regimens
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026-2033
      1. TNF-α Inhibitors
      2. IL-12/23 Inhibitors
      3. IL-17 Inhibitors
      4. IL-23 Inhibitors
      5. PDE4 Inhibitors
      6. TYK2 Inhibitors
      7. Other
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  8. Europe Psoriasis Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Treatment Modality
      3. By Drug Class
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026-2033
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
    3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Modality, 2026-2033
      1. Biologic Drugs
      2. Small-molecule Systemic Drugs
      3. Topical Agents
      4. Combination Regimens
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026-2033
      1. TNF-α Inhibitors
      2. IL-12/23 Inhibitors
      3. IL-17 Inhibitors
      4. IL-23 Inhibitors
      5. PDE4 Inhibitors
      6. TYK2 Inhibitors
      7. Other
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  9. East Asia Psoriasis Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Treatment Modality
      3. By Drug Class
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026-2033
      1. China
      2. Japan
      3. South Korea
    3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Modality, 2026-2033
      1. Biologic Drugs
      2. Small-molecule Systemic Drugs
      3. Topical Agents
      4. Combination Regimens
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026-2033
      1. TNF-α Inhibitors
      2. IL-12/23 Inhibitors
      3. IL-17 Inhibitors
      4. IL-23 Inhibitors
      5. PDE4 Inhibitors
      6. TYK2 Inhibitors
      7. Other
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  10. South Asia & Oceania Psoriasis Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Treatment Modality
      3. By Drug Class
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026-2033
      1. India
      2. Indonesia
      3. Thailand
      4. Singapore
      5. ANZ
      6. Rest of South Asia & Oceania
    3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Modality, 2026-2033
      1. Biologic Drugs
      2. Small-molecule Systemic Drugs
      3. Topical Agents
      4. Combination Regimens
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026-2033
      1. TNF-α Inhibitors
      2. IL-12/23 Inhibitors
      3. IL-17 Inhibitors
      4. IL-23 Inhibitors
      5. PDE4 Inhibitors
      6. TYK2 Inhibitors
      7. Other
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  11. Latin America Psoriasis Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Treatment Modality
      3. By Drug Class
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026-2033
      1. Brazil
      2. Mexico
      3. Rest of Latin America
    3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Modality, 2026-2033
      1. Biologic Drugs
      2. Small-molecule Systemic Drugs
      3. Topical Agents
      4. Combination Regimens
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026-2033
      1. TNF-α Inhibitors
      2. IL-12/23 Inhibitors
      3. IL-17 Inhibitors
      4. IL-23 Inhibitors
      5. PDE4 Inhibitors
      6. TYK2 Inhibitors
      7. Other
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  12. Middle East & Africa Psoriasis Drugs Market Outlook
    1. Historical Market Size (US$ Bn) Analysis, By Market, 2020-2025
      1. By Country
      2. By Treatment Modality
      3. By Drug Class
      4. By Distribution Channel
    2. Market Size (US$ Bn) Analysis and Forecast, By Country, 2026-2033
      1. GCC Countries
      2. Egypt
      3. South Africa
      4. Northern Africa
      5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) Analysis and Forecast, By Treatment Modality, 2026-2033
      1. Biologic Drugs
      2. Small-molecule Systemic Drugs
      3. Topical Agents
      4. Combination Regimens
    4. Market Size (US$ Bn) Analysis and Forecast, By Drug Class, 2026-2033
      1. TNF-α Inhibitors
      2. IL-12/23 Inhibitors
      3. IL-17 Inhibitors
      4. IL-23 Inhibitors
      5. PDE4 Inhibitors
      6. TYK2 Inhibitors
      7. Other
    5. Market Size (US$ Bn) Analysis and Forecast, By Distribution Channel, 2026-2033
      1. Hospital Pharmacies
      2. Retail Pharmacies
      3. Online Pharmacies
    6. Market Attractiveness Analysis
  13. Competition Landscape
    1. Market Share Analysis, 2025
    2. Market Structure
      1. Competition Intensity Mapping By Market
      2. Competition Dashboard
    3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
      1. AbbVie Inc.
        1. Overview
        2. Segments and Treatment Modality
        3. Key Financials
        4. Market Developments
        5. Market Strategy
      2. Johnson & Johnson Services Inc.
      3. Novartis AG
      4. Eli Lilly and Company
      5. Amgen Inc.
      6. Bristol Myers Squibb Company
      7. Pfizer Inc.
      8. Sun Pharmaceutical Industries Ltd.
      9. Boehringer Ingelheim Intl. GmbH
      10. Leo Pharma A/S
      11. Dr. Reddy’s Laboratories Ltd.
      12. Takeda Pharmaceutical Co. Ltd.
      13. Others
  14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations
Emailsales@persistencemarketresearch.com
UK

Corporate Office

Persistence Research & Consultancy Services Limited

Company Number : 15310893

Second Floor, 150 Fleet Street,London, EC4A 2DQ.

+44 203-837-5656
USA

Regional Office

Persistence Market Research

108 W 39th Street, Ste 1006,PMB2219, New York, NY 10018

+1 646-878-6329
India

Global Research centre

Persistence Market Research Private Limited

CIN : U74900PN2014PTC153163

IT Unit No. 504, 5th Floor, IconTower, Baner, Pune - 411045.

+91 906 779 3500SIN : +65 6531 3894 98
Quick Links
CareersTerms & ConditionsReturn PolicyMarket Research Report
Customer FAQ’sPrivacy PolicySitemap

Copyright © 2026 Persistence Market Research. All Rights Reserved

Connect With Us -